Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
<p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , , , , , , , , , , , |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| _version_ | 1849927632821420032 |
|---|---|
| author | Nicole A. Traphagen (16677391) |
| author2 | Gary N. Schwartz (16005870) Steven Tau (16677394) Alyssa M. Roberts (16677397) Amanda Jiang (15117790) Sarah R. Hosford (16677400) Jonathan D. Marotti (16005879) Abigail E. Goen (16677403) Bianca A. Romo (16677406) Anneka L. Johnson (16677409) Emily-Claire K. Duffy (16677412) Eugene Demidenko (16005894) Paul Heverly (16677415) Yaron Mosesson (16677418) Shannon M. Soucy (16005888) Fred Kolling (16005891) Todd W. Miller (16005897) |
| author2_role | author author author author author author author author author author author author author author author author |
| author_facet | Nicole A. Traphagen (16677391) Gary N. Schwartz (16005870) Steven Tau (16677394) Alyssa M. Roberts (16677397) Amanda Jiang (15117790) Sarah R. Hosford (16677400) Jonathan D. Marotti (16005879) Abigail E. Goen (16677403) Bianca A. Romo (16677406) Anneka L. Johnson (16677409) Emily-Claire K. Duffy (16677412) Eugene Demidenko (16005894) Paul Heverly (16677415) Yaron Mosesson (16677418) Shannon M. Soucy (16005888) Fred Kolling (16005891) Todd W. Miller (16005897) |
| author_role | author |
| dc.creator.none.fl_str_mv | Nicole A. Traphagen (16677391) Gary N. Schwartz (16005870) Steven Tau (16677394) Alyssa M. Roberts (16677397) Amanda Jiang (15117790) Sarah R. Hosford (16677400) Jonathan D. Marotti (16005879) Abigail E. Goen (16677403) Bianca A. Romo (16677406) Anneka L. Johnson (16677409) Emily-Claire K. Duffy (16677412) Eugene Demidenko (16005894) Paul Heverly (16677415) Yaron Mosesson (16677418) Shannon M. Soucy (16005888) Fred Kolling (16005891) Todd W. Miller (16005897) |
| dc.date.none.fl_str_mv | 2025-11-25T13:21:08Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708354 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Estrogen_Therapy_Induces_Receptor-Dependent_DNA_Damage_Enhanced_by_PARP_Inhibition_in_ER_Breast_Cancer/30708354 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Breast Cancer Drug Mechanisms Cellular responses to anticancer drugs Drug Resistance Reversal of drug resistance |
| dc.title.none.fl_str_mv | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_8c1f656d28b21fba8da99f0e798e33df |
| identifier_str_mv | 10.1158/1078-0432.30708354 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708354 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast CancerNicole A. Traphagen (16677391)Gary N. Schwartz (16005870)Steven Tau (16677394)Alyssa M. Roberts (16677397)Amanda Jiang (15117790)Sarah R. Hosford (16677400)Jonathan D. Marotti (16005879)Abigail E. Goen (16677403)Bianca A. Romo (16677406)Anneka L. Johnson (16677409)Emily-Claire K. Duffy (16677412)Eugene Demidenko (16005894)Paul Heverly (16677415)Yaron Mosesson (16677418)Shannon M. Soucy (16005888)Fred Kolling (16005891)Todd W. Miller (16005897)CancerTherapeutic Research and DevelopmentBreast CancerDrug MechanismsCellular responses to anticancer drugsDrug ResistanceReversal of drug resistance<p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>2025-11-25T13:21:08ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708354https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Estrogen_Therapy_Induces_Receptor-Dependent_DNA_Damage_Enhanced_by_PARP_Inhibition_in_ER_Breast_Cancer/30708354CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307083542025-11-25T13:21:08Z |
| spellingShingle | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer Nicole A. Traphagen (16677391) Cancer Therapeutic Research and Development Breast Cancer Drug Mechanisms Cellular responses to anticancer drugs Drug Resistance Reversal of drug resistance |
| status_str | publishedVersion |
| title | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| title_full | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| title_fullStr | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| title_full_unstemmed | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| title_short | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| title_sort | Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer |
| topic | Cancer Therapeutic Research and Development Breast Cancer Drug Mechanisms Cellular responses to anticancer drugs Drug Resistance Reversal of drug resistance |